WallStreetZenWallStreetZen

NASDAQ: XCUR
Exicure Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

XCUR past earnings growth

How has XCUR's earnings growth performed historically?
Company
N/A
Industry
52.11%
Market
105.88%
XCUR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
XCUR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

XCUR past revenue growth

How has XCUR's revenue growth performed historically?
Company
584.21%
Industry
149.3%
Market
17.29%
XCUR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XCUR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XCUR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

XCUR earnings and revenue history

Current Revenue
$23.8M
Current Earnings
$3.1M
Current Profit Margin
12.9%

XCUR Return on Equity

Current Company
34.5%
Current Industry
1.3%
Current Market
-0.3%
XCUR's Return on Equity (34.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XCUR announces earnings.

XCUR Return on Assets

Current Company
13.1%
Current Industry
-1.5%
XCUR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XCUR Return on Capital Employed

Current Company
20.31%
Current Industry
11.8%
XCUR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XCUR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XCUR$23.79M$5.04M$3.07M+38.63%-72.96%
LGVN$709.00k-$20.47M-$22.21M-19.78%N/A
NLSP$0.00-$15.36M-$15.47MN/AN/A
ALZN$0.00-$12.35M-$12.40MN/AN/A
SNPX$0.00-$6.03M-$13.78MN/AN/A
View Top Biotech Stocks

Exicure Earnings & Revenue FAQ

What were XCUR's earnings last quarter?

On Invalid Date, Exicure (NASDAQ: XCUR) reported Q2 2023 earnings per share (EPS) of -$0.68, up 59.04% year over year. Total Exicure earnings for the quarter were -$5.76 million. In the same quarter last year, Exicure's earnings per share (EPS) was -$1.66.

If you're new to stock investing, here's how to buy Exicure stock.

What was XCUR's earnings growth in the past year?

As of Q2 2024, Exicure's earnings has grown year over year. Exicure's earnings in the past year totalled $3.07 million.

What was XCUR's revenue last quarter?

On Invalid Date, Exicure (NASDAQ: XCUR) reported Q2 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Exicure's revenue was $2.47 million.

What was XCUR's revenue growth in the past year?

As of Q2 2024, Exicure's revenue has grown 584.21% year over year. This is 434.91 percentage points higher than the US Biotechnology industry revenue growth rate of 149.3%. Exicure's revenue in the past year totalled $23.79 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.